Inneh, A
#GLP1 #MetabolicHealth #Obesity #Type2Diabetes #Pharmaceuticals #DrugDevelopment #Biopharma #CardiometabolicHealth #HealthcareInnovation #PrecisionMedicine To view or add a comment, sign in : $ The global Type 2 Diabetes market was valued at USD 41.5 billion in 2025 and is projected to reach USD 85.0 billion by 2035, growing at a CAGR of 7.69% (20262035), per SNS Insider's latest market report
So the goal became clear: build a better, more compassionate path to weight lossone that combines cutting-edge medicine with support and simplicity. Sprout Health uses a white-label telehealth service According to Sprouts terms and conditions, it uses a white label telehealth provider called MD Integrations
As obesity rates continue to rise, diabetes cases are climbing in tandem
No microneedle GLP-1 patch has been approved for human use anywhere in the world
[31] One fatality has been confirmed since 1930, on February 16, 2024, [35] and the rare fatalities recorded before 1930 occurred in adults who were intoxicated by alcohol or had mismanaged the treatment of the bite